Form 483

Neogen Corporation Form 483, 2023-12-21

FDA issued a Form 483 to Neogen Corporation on 2023-12-21 with 4 public-safe observations.

483· Form 483 issuedHuman Drugs4 observations

Neogen Corporation · Lexington, United States · Issued December 21, 2023

Overview

  • 4 public-safe observations are available for this inspection.
  • 2 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

21 Dec 2023
21 CFR 211.113(a)

Procedures for non-sterile drug products

Cited by Logan T Williams

21 Dec 2023
21 CFR 211.113(a)

Procedures for non-sterile drug products

Cited by Logan T Williams

21 Dec 2023
21 CFR 211.67(a)

Cleaning / Sanitizing / Maintenance

Cited by Logan T Williams

21 Dec 2023
21 CFR 211.67(a)

Cleaning / Sanitizing / Maintenance

Cited by Logan T Williams

Inspected site

NCNeogen CorporationLexington, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.113(a)Cited across public-safe Form 483 observations2x
21 CFR 211.67(a)Cited across public-safe Form 483 observations2x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Full 483 report

Get the verbatim text of all 4 observations

The source PDF, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere